The Effects of Biocompatible Compared with Standard Peritoneal Dialysis Solutions on Peritonitis Microbiology, Treatment, and Outcomes: the balANZ Trial

♦ Background: A multicenter, multi-country randomized controlled trial (the balANZ study) recently reported that peritonitis rates significantly improved with the use of neutral-pH peritoneal dialysis (PD) solutions low in glucose degradation products (“biocompatible”) compared with standard solutio...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Johnson, David W., Brown, Fiona G., Clarke, Margaret, Boudville, Neil, Elias, Tony J., Foo, Marjorie W.Y., Jones, Bernard, Kulkarni, Hemant, Langham, Robyn, Ranganathan, Dwarakanathan, Schollum, John, Suranyi, Michael G., Tan, Seng H., Voss, David
Formato: Artigo
Idioma:Inglês
Publicado em: Multimed Inc 2012
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3524863/
https://ncbi.nlm.nih.gov/pubmed/22991015
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/pdi.2012.00052
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados